bcl-2 protein downregulation is not required for differentiation of multidrug resistant HL60 leukemia cells.

[1]  W. Mercer,et al.  p53-independent induction of WAF1/CIP1 in human leukemia cells is correlated with growth arrest accompanying monocyte/macrophage differentiation. , 1995, Cancer research.

[2]  Z. Su,et al.  Induction of differentiation in human promyelocytic HL-60 leukemia cells activates p21, WAF1/CIP1, expression in the absence of p53. , 1994, Oncogene.

[3]  C. Guillouf,et al.  Induction of p21 (WAF-1/CIP1) during differentiation. , 1994, Oncogene.

[4]  L. Neckers,et al.  Inhibition of heat shock protein HSP90-pp60v-src heteroprotein complex formation by benzoquinone ansamycins: essential role for stress proteins in oncogenic transformation. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[5]  T. Takizawa,et al.  Differential expression of bcl-2 and susceptibility to anti-Fas-mediated cell death in peripheral blood lymphocytes, monocytes, and neutrophils. , 1994, Blood.

[6]  S. Collins,et al.  Dysregulated bcl-2 expression inhibits apoptosis but not differentiation of retinoic acid-induced HL-60 granulocytes. , 1994, Blood.

[7]  John Calvin Reed,et al.  Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. , 1994, Oncogene.

[8]  M. Cleary,et al.  Bcl2 inhibits apoptosis associated with terminal differentiation of HL-60 myeloid leukemia cells. , 1994, Blood.

[9]  Yi-Song Wang,et al.  WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. , 1994, Cancer research.

[10]  L. Neckers,et al.  Cytostatic and cytotoxic activity of sex steroids against human leukemia cell lines. , 1994, Cancer letters.

[11]  John Calvin Reed Bcl-2 and the regulation of programmed cell death , 1994, The Journal of cell biology.

[12]  C. Tepper,et al.  1,25-Dihydroxyvitamin D3 protects HL60 cells against apoptosis but down-regulates the expression of the bcl-2 gene. , 1993, Experimental cell research.

[13]  Z. Oltvai,et al.  Bcl-2/Bax: a rheostat that regulates an anti-oxidant pathway and cell death. , 1993, Seminars in cancer biology.

[14]  J. Trent,et al.  WAF1, a potential mediator of p53 tumor suppression , 1993, Cell.

[15]  C. Thompson,et al.  bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death , 1993, Cell.

[16]  S. Korsmeyer,et al.  Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell death , 1993, Cell.

[17]  R. Mohammad,et al.  Prothymosin alpha gene expression correlates with proliferation, not differentiation, of HL-60 cells. , 1993, Blood.

[18]  R. Glazer,et al.  Reversal of resistance to adriamycin by 8-chloro-cyclic AMP in adriamycin-resistant HL-60 leukemia cells is associated with reduction of type I cyclic AMP-dependent protein kinase and cyclic AMP response element-binding protein DNA-binding activities. , 1993, Molecular pharmacology.

[19]  S. Korsmeyer Bcl-2 initiates a new category of oncogenes: regulators of cell death. , 1992, Blood.

[20]  D. Kufe,et al.  Internucleosomal DNA fragmentation during phorbol ester-induced monocytic differentiation and G0/G1 arrest. , 1992, The Journal of clinical investigation.

[21]  M. Pierotti,et al.  bcl-2 proto-oncogene expression in normal and neoplastic human myeloid cells. , 1992, Blood.

[22]  S. Bates,et al.  Use of the polymerase chain reaction in the quantitation of mdr-1 gene expression. , 1990, Biochemistry.

[23]  S. Collins,et al.  Expression of the beta-subunit of the human leukocyte adherence receptor depends upon cell type and stage of differentiation. , 1988, Journal of Immunology.

[24]  K. D. Hartman,et al.  Role of protein kinase C in phosphorylation of vinculin in adriamycin-resistant HL-60 leukemia cells. , 1988, Cancer research.

[25]  R. Locksley,et al.  Expression of leukocyte adherence-related glycoproteins during differentiation of HL-60 promyelocytic leukemia cells. , 1987, Journal of immunology.

[26]  V. Rotter,et al.  Major deletions in the gene encoding the p53 tumor antigen cause lack of p53 expression in HL-60 cells. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[27]  John Calvin Reed,et al.  Reversal of chemoresistance of lymphoma cells by antisense-mediated reduction of bcl-2 gene expression. , 1994, Antisense research and development.